Loading...
Market
Will a major pharmaceutical company launch a new aspirin product specifically marketed for cancer prevention by December 31, 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Press release or official product launch announcement
Story
Harvard Study: Daily Aspirin Use Reduces Colorectal Cancer Risk by a Third
Aug 1, 2024, 03:15 PM
A major study has found that regular use of aspirin can significantly reduce the risk of developing colorectal cancer, even among individuals with unhealthy lifestyles. The study, conducted by researchers at Harvard and MassGenBrigham and published in JAMA Oncology, indicates that taking aspirin daily may reduce the risk of colon cancer by up to a third. This protective effect is believed to be due to aspirin's ability to block polyps, which are precursors to cancer. The findings offer hope for preventing colorectal cancer, which is a growing epidemic.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Johnson & Johnson • 25%
Merck • 25%
AstraZeneca • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%